Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.

about

Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding.

P2860

Q52660986-509A59CC-2BBA-435C-8FC6-DFBA888A7059

P2860

Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.

Item

http://www.wikidata.org/entity/Q47878536

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Second Generation Grp94-Select ...... hibition of Metastatic Cancer.

@en

Second Generation Grp94-Select ...... hibition of Metastatic Cancer.

@nl

type

Item

label

Second Generation Grp94-Select ...... hibition of Metastatic Cancer.

@en

Second Generation Grp94-Select ...... hibition of Metastatic Cancer.

@nl

prefLabel

Second Generation Grp94-Select ...... hibition of Metastatic Cancer.

@en

Second Generation Grp94-Select ...... hibition of Metastatic Cancer.

@nl

P1476

Second Generation Grp94-Select ...... nhibition of Metastatic Cancer

@en

P2093

Dustin J E Huard

http://www.w3.org/2001/XMLSchema#string

Raquel L Lieberman

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Structures of GRP94-nucleotide complexes reveal mechanistic differences between the hsp90 chaperones

Paralog Specific Hsp90 Inhibitors - A Brief History and a Bright Future

GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum

Different Poses for Ligand and Chaperone in Inhibitor-Bound Hsp90 and GRP94: Implications for Paralog-Specific Drug Design

Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity-Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases

Synthesis of macrolactam analogues of radicicol and their binding to heat shock protein Hsp90

XDS

P304

15775-15782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CHEM.201703398

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincent M. Crowley

Brian S J Blagg

P577

2017-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28857290

http://www.w3.org/2001/XMLSchema#string

P932

5722212

http://www.w3.org/2001/XMLSchema#string

Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.

about

P2860

P2860

Second Generation Grp94-Selective Inhibitors Provide Opportunities for the Inhibition of Metastatic Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932